Peter Pitts on communicating with FDA
This article was originally published in The Gray Sheet
Former Associate Commissioner for External Relations will address AdvaMed Medical Technology Communications Conference Oct. 13 in his current role as senior VP-health affairs at New York PR firm Manning, Salvage & Lee. Pitts' luncheon speech will cover the "boundaries of company communications versus FDA communications, best ways to bridge communications gaps with the agency and its use of the Web to promote company advisories," according to an 1agenda for the two-day Washington, D.C. meeting...
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.